N-<(thienyl-2)-methyl>-ethylenediamine | 51171-31-4

• 分子结构分类: 有机化合物 - 有机氮化合物
• 英文名称: N-<(thienyl-2)-methyl>-ethylenediamine
• 英文别名: N-(thienyl-2-methyl)ethylenediamine；N-(2-thienylmethyl)ethylenediamine；N-(2-Thenylmethyl)ethylenediamine；N-thiophen-2-ylmethyl-ethane-1,2-diamine；N-(α-Thienylmethyl)-ethylendiamin；N-(Thienyl-(2)-methyl)-1,2-diaminoethan；N'-(thiophen-2-ylmethyl)ethane-1,2-diamine
• CAS: 51171-31-4
• 化学式: C₇H₁₂N₂S
• 分子量: 156.252
• InChiKey: PMVKNSKIASQUCS-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.1
• 重原子数：
  10
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.43
• 拓扑面积：
  66.3
• 氢给体数：
  2
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  N-<(thienyl-2)-methyl>-ethylenediamine 以 乙醇 、 乙腈 为溶剂， 反应 4.0h， 生成 (Z)-N-[2-nitro-2-[1-(2-thienylmethyl)-2-imidazolidinylidene]thioacetyl]benzamide
  参考文献：
  名称：

  Design, synthesis, and bioactivity of cyanonitrovinyl neonicotinoids as potential insecticides

  摘要：

  A series of cyanonitrovinyl neonicotinoids were designed and synthesized via five steps in about 35% overall yields. All compounds were structurally characterized by (1)H nuclear magnetic resonance (NMR), (13)C NMR, infrared (IR), and high-resolution mass spectrometry (HRMS), and single-crystal X-ray diffraction analysis of 2-[1-[(6-chloropyridin-3-yl)methyl]-2-imidazolidinylidene]-2-nitroacetonitrile revealed that the double bond is (E)-configured. The preliminary agriculture bioassay indicated that one compound exhibited moderate insecticidal activity against pea aphid.

  DOI：

  10.1007/s00706-010-0375-4
• 作为产物：
  描述：

  2-氯甲基噻吩 、 乙二胺 以 乙腈 为溶剂， 生成 N-<(thienyl-2)-methyl>-ethylenediamine
  参考文献：
  名称：

  以咪唑啉为潜在杀菌剂的不对称二氟硼配合物的设计、合成和评价

  摘要：

  通过新的螯合配体（芳甲基-咪唑啉亚基）-吡啶-2-基-胺与三氟化硼乙醚化物的反应，合成了一系列与吡啶和咪唑啉的不对称二氟-硼（BF2）配合物。所有配体和 BF2 配合物均通过 IR、HRMS、1H、13C、11B 和 19F NMR 进行结构表征，表明咪唑啉氮和吡啶氮与硼中心的双齿络合。农业生物活性评价表明，一些 BF2 复合物表现出中等的杀真菌活性，大多数 BF2 复合物表现出比非 BF2 复合底物更高的活性。© 2010 Wiley Periodicals, Inc. 杂原子化学 20:418–424, 2009; 在线发表于 Wiley InterScience (www.interscience.wiley.com)。DOI 10.1002/hc.20567

  DOI：

  10.1002/hc.20567

文献信息

• Substituted piperidines and methods of use
  申请人：——

  公开号：US20040006067A1

  公开（公告）日：2004-01-08

  Selected substituted piperidine compounds are effective for prophylaxis and treatment of diseases, such as obesity and the like. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving activation of the melanocortin receptor. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.

  选定的替代哌啶化合物对预防和治疗疾病，如肥胖等，具有有效性。该发明涵盖了新颖化合物、类似物、前药和其药用可接受盐，以及用于预防和治疗涉及黑素皮质素受体激活的疾病和其他疾病或病症的药物组合物和方法。该发明还涉及制备此类化合物的方法，以及在此类方法中有用的中间体。
• Substituted piperazines and methods of use
  申请人：——

  公开号：US20030220324A1

  公开（公告）日：2003-11-27

  Selected substituted piperazine compounds are effective for prophylaxis and treatment of diseases, such as obesity and the like. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving activation of the melanocortin receptor. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.

  选择的替代哌嗪化合物对于预防和治疗疾病，如肥胖等，具有有效性。该发明涵盖了新型化合物、类似物、前药和其药用盐，以及用于预防和治疗涉及黑素皮质素受体激活的疾病和其他疾病或病症的药物组合物和方法。该发明还涉及制备这类化合物的方法，以及在这些过程中有用的中间体。
• Design, synthesis, and evaluation of unsymmetrical difluoro-boron complexes with imidazoline as potential fungicides
  作者：Kewei Wang、Jingnan Cui、Lijuan Xie、Xuhong Qian

  DOI：10.1002/hc.20567

  日期：——

  complexes with pyridine and imidazoline were synthesized by reaction of new chelating ligands (arylmethyl-imidazolidinylidene)-pyridin-2-yl-amine with boron trifluoride diethyl etherate. All the ligands and BF2 complexes were structurally characterized by IR, HRMS, 1H, 13C,11B, and 19F NMR, indicating the bidentate complexation of imidazoline nitrogen and the pyridine nitrogen to the boron center. Evaluation

  通过新的螯合配体（芳甲基-咪唑啉亚基）-吡啶-2-基-胺与三氟化硼乙醚化物的反应，合成了一系列与吡啶和咪唑啉的不对称二氟-硼（BF2）配合物。所有配体和 BF2 配合物均通过 IR、HRMS、1H、13C、11B 和 19F NMR 进行结构表征，表明咪唑啉氮和吡啶氮与硼中心的双齿络合。农业生物活性评价表明，一些 BF2 复合物表现出中等的杀真菌活性，大多数 BF2 复合物表现出比非 BF2 复合底物更高的活性。© 2010 Wiley Periodicals, Inc. 杂原子化学 20:418–424, 2009; 在线发表于 Wiley InterScience (www.interscience.wiley.com)。DOI 10.1002/hc.20567
• One step from nitro to oxime: a convenient preparation of unsaturated oximes by the reduction of the corresponding vinylnitro compounds
  作者：Kewei Wang、Xuhong Qian、Jingnan Cui

  DOI：10.1016/j.tet.2009.10.042

  日期：2009.12

  A series of novel unsaturated oximes were conveniently prepared from the corresponding vinylnitro compounds by reduction with SnCl2·2H2O. The structures of the oximes were characterized by 1H and 13C NMR, IR and HRMS, and X-ray crystallography analysis of 1-(6-chloro-pyridin-3-ylmethyl)-4,5-dihydro-1H-imidazole-2-carbaldehyde oxime 2a reveals that, the hydroxyl group is arranged in a trans configuration

  可以通过相应的乙烯基硝基化合物通过SnCl 2 ·2H 2 O还原而方便地制备一系列新型不饱和肟。肟的结构通过1 H和13 C NMR，IR和HRMS以及X射线晶体学分析进行表征。 1-（6-氯-吡啶-3-基甲基）-4，5-二氢-1H-咪唑-2-甲醛甲醛肟2a表明，羟基以反式构型排列。简短调查的一些证据表明，这些肟似乎是由硝基脂族化合物的aci形式还原而形成的。
• [EN] SUBSTITUTED PIPERAZINES AS MODULATORS OF THE MELANOCORTIN RECEPTOR<br/>[FR] PIPERAZINES SUBSTITUEES COMME MODULATEURS DU RECEPTEUR DE MELANOCORTINE
  申请人：AMGEN INC

  公开号：WO2003009850A1

  公开（公告）日：2003-02-06

  Selected substituted piperazine compounds are effective for prophylaxis and treatment of diseases, such as obesity and the like. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving activation of the melanocortin receptor. The subject invention also relates to processes For making such compounds as well as to intermediates useful in such processes.

  选定的取代哌嗪化合物可用于预防和治疗疾病，如肥胖症等。该发明涵盖了新化合物、类似物、前药及其药学上可接受的盐、制药组合物以及用于预防和治疗涉及黑色素皮质素受体激活的疾病和其他疾病或病症的方法。该发明还涉及制造这些化合物的过程，以及在此类过程中有用的中间体。